<DOC>
	<DOC>NCT00653562</DOC>
	<brief_summary>To evaluate the efficacy of zolpidem for adolescent insomniacs with polysomnography</brief_summary>
	<brief_title>Zolpidem (Myslee) Post Marketing Study in Adolescent Patients With Insomnia - Evaluation With Polysomnography</brief_title>
	<detailed_description>The study consists of two parts. All patients will receive placebo in one part and Zolpidem in the other part in a single blind manner. Efficacy will be measured with polysomnography .</detailed_description>
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>Patients diagnosed as having nonorganic insomnia of nonorganic sleep disorder in ICD10 Patients with schizophrenia or manicdepressive illness Patients with insomnia caused by physical diseases Patients having a history of hypersensitivity to zolpidem Patients with attentiondeficit hyperactivity disorder</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>polysomnography</keyword>
	<keyword>zolpidem</keyword>
	<keyword>Sleep disorders</keyword>
	<keyword>adolescent</keyword>
</DOC>